Veterinary Medicine Information website

Tetra-Delta (105 mg + 100 000 j.m. + 100 mg + 100 mg + 10 mg) /10 ml Zawiesina dowymieniowa

Not authorised
  • Prednisolone
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Neomycin
  • Novobiocin sodium

Product identification

Medicine name:
Tetra-Delta (105 mg + 100 000 j.m. + 100 mg + 100 mg + 10 mg) /10 ml Zawiesina dowymieniowa
Active substance:
  • Prednisolone
  • Benzylpenicillin procaine
  • Dihydrostreptomycin sulfate
  • Neomycin
  • Novobiocin sodium
Target species:
  • Cattle
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Prednisolone
    10.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Benzylpenicillin procaine
    100000.00
    international unit(s)
    /
    1.00
    international unit(s)
  • Dihydrostreptomycin sulfate
    100.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Neomycin
    105.00
    milligram(s)
    /
    10.00
    millilitre(s)
  • Novobiocin sodium
    100.00
    milligram(s)
    /
    10.00
    millilitre(s)
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle
      • Meat and offal
        5
        week
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51RV01
Authorisation status:
  • Surrendered
Authorised in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Zoetis Polska Sp. z o.o.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
  • Norbrook Laboratories Limited
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0259
Date of authorisation status change:

Documents

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022